Title:
METHOD FOR COLLECTING DATA FOR PREDICTING ADMINISTRATION EFFECTIVENESS OF IMMUNE CHECKPOINT INHIBITOR TO CANCER PATIENT
Document Type and Number:
Japanese Patent JP2021136934
Kind Code:
A
Abstract:
To provide a novel technique of predicting administration effectiveness of an immune checkpoint inhibitor.SOLUTION: A method for collecting data for predicting administration effectiveness of an immune checkpoint inhibitor to a cancer patient, which includes a process of measuring an expression level of a marker gene or a marker protein in a biological sample derived from the cancer patient. In the method, the marker gene or marker protein includes NELL2 gene or protein, AMICA1 gene or protein, CLEC11A gene or protein, CLECL1 gene or protein or CMTM7 gene or protein, the expression level is data for predicting the effectiveness, and the fact that the expression level is higher than a reference value indicates that administration of the immune checkpoint inhibitor to the cancer patient is effective.SELECTED DRAWING: None
More Like This:
Inventors:
KAWAKAMI YUTAKA
OTA SHIGEKI
MATSUMOTO DAICHI
OTA SHIGEKI
MATSUMOTO DAICHI
Application Number:
JP2020037980A
Publication Date:
September 16, 2021
Filing Date:
March 05, 2020
Export Citation:
Assignee:
KEIO GIJUKU
International Classes:
A61K35/76; C12Q1/6851; A61K38/02; A61K39/395; A61K45/00; A61K48/00; A61P35/00; A61P37/04; C12Q1/6813; C12Q1/686; G01N33/15; G01N33/50; G01N33/53; G01N33/574; G01N33/68
Attorney, Agent or Firm:
Sumio Tanai
Masato Iida
Hirotaka Haruta
Hiroshi Yamaguchi
Masato Iida
Hirotaka Haruta
Hiroshi Yamaguchi